CERK might contribute to inflammatory pain; Comments on Yu WL, Sun. Y (2015). CERK inhibition might be a good potential therapeutic target for diseases. Br J Pharmacol 172: 2165.

Huang, Jin-lu; Huo, Yan; Wan, Li-li; Yang, Quan-jun; Li, Jie; Guo, Cheng

Huang, Jin-lu; Huo, Yan; Wan, Li-li; Yang, Quan-jun; Li, Jie; Guo, Cheng.

Affiliation

Huang JL; Department of Pharmacy, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
Huo Y; Department of Pharmacy, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
Wan LL; Department of Pharmacy, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
Yang QJ; Department of Pharmacy, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
Li J; Department of Pharmacy, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
Guo C; Department of Pharmacy, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.

Br J Pharmacol ; 173(7): 1248-9, 2016 Apr.

Article in En | MEDLINE | ID: mdl-26989987

Subject(s)

Apoptosis/drug effects; Benzothiazoles/pharmacology; Breast Neoplasms; Bridged-Ring Compounds/pharmacology; Cell Proliferation/drug effects; Enzyme Inhibitors/pharmacology; Lung Neoplasms; M Phase Cell Cycle Checkpoints/drug effects; Phosphotransferases (Alcohol Group Acceptor)/antagonists & inhibitors; Tumor Stem Cell Assay; Humans

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Bridged-Ring Compounds / Tumor Stem Cell Assay / Apoptosis / Phosphotransferases (Alcohol Group Acceptor) / Cell Proliferation / Enzyme Inhibitors / Benzothiazoles / M Phase Cell Cycle Checkpoints / Lung Neoplasms Limits: Humans Language: En Journal: Br J Pharmacol Year: 2016 Type: Article Affiliation country: China

Fulltext

XML

PubMed Links

Search on Google